Sign in

CIK 0001553643

  • Non-accelerated filer
  • Smaller reporting company

RELMADA THERAPEUTICS, INC.

Sign in to watch
Ticker
RLMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
455401931
Phone
+1 646-876-3459
Business address
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
Former names
CAMP NINE, INC.
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Chief Operating Officer bought 200,000 shares at $0.43 ($86,060)
  3. 4 Open-market buy Chief Financial Officer bought 200,000 shares at an average $0.49 ($97,208)
  4. 4 Open-market buy CA and CO bought 228,961 shares at $0.45 ($103,330)
  5. 4 Open-market buy Chief Executive Officer bought 350,000 shares at an average $0.50 ($174,713)
  6. 4 Gift Director gave 13,000 shares (gift)
  7. 4 Open-market buy Chief Executive Officer bought 140,000 shares at an average $2.82 ($395,115)
  8. 4 Open-market buy Director bought 13,000 shares at $2.56 ($33,280)
  9. 4 Open-market buy Chief Financial Officer bought 53,432 shares at an average $2.80 ($149,701)
  10. 4 Open-market buy Director bought 25,000 shares at $2.59 ($64,750)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Chief Executive Officer bought 100,000 shares at an average $3.87 ($386,738)
  19. 4 Open-market buy Chief Financial Officer bought 32,675 shares at an average $3.85 ($125,717)
  20. 4 Open-market buy CA and CO bought 38,970 shares at an average $3.87 ($150,920)

Page 2 of 10 · 200 filings